Dr. Randolph Marshall, MD

Dr. Marshall practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Marshall's NPI, 1588753032, was assigned on October 12, 2006. Dr. Marshall graduated from UCSF School of Medicine in 1988. Dr. Marshall holds New York license 181338.

Dr. Marshall's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Marshall's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Marshall is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Marshall to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marshall practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Marshall's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Marshall is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Marshall's licenses on file in 3 states: New York, Connecticut and New Jersey.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, head injury, migraine and chronic headache, mini-stroke (TIA), sleep apnea, stroke and vertigo among the conditions Dr. Marshall treats.

CMS data shows 502 Medicare services from Dr. Marshall across 8 procedure codes in 2024, for 368 Medicare patients. Medicare paid $71,759 for them.

CMS counts 368 Medicare patients who saw Dr. Marshall in 2024. The largest group is 75 to 84, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marshall's median patient age at 68, with 43% women.

In 2024, Dr. Marshall wrote 312 Medicare Part D claims for 92 patients. 95% of them were for generic drugs. CMS names the drug for 189 of them, across 9 drugs with 11 or more claims each, at $3,350 in total drug cost. In 2023, CMS named 206 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Marshall for performance year 2024, reported through an alternative payment model (APM). Dr. Marshall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marshall as offering telehealth.

Dmand AI links 219 papers to Dr. Marshall, published from 2003 to 2025. 2016 was the busiest year, with 15. The most frequent topics are Stroke, Magnetic Resonance Imaging and Brain. Dr. Marshall has published most often in Neurology. Dr. Marshall's most frequent co-authors are Joshua Zebadiah Willey, MD, Mitchell S. Elkind, MD and Shadi Yaghi, MD.

Dmand AI links Dr. Marshall to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Carotid Artery Diseases, Cerebrovascular Disorders and Carotid Stenosis. Columbia University sponsors the most, 3.

CMS Open Payments shows 3 general payments to Dr. Marshall from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $49.

Dmand AI lists 9 awards for Dr. Marshall, most recently Adolph Sahs Lectureship in 2018.

Dr. Marshall graduated from UCSF School of Medicine in 1988. Dr. Marshall is a member of AAN.

Dr. Marshall is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.